Citation Impact
Citing Papers
Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma
2008
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer
1999
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Physiologic Mechanisms of Therapeutic Resistance: Blood Flow and Hypoxia
1995
Catalytic Asymmetric Three‐Component Synthesis of Homoallylic Amines
2013 StandoutNobel
Nasopharyngeal carcinoma
2005 Standout
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
1991
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer
2003
Dexrazoxane does not protect against doxorubicin-induced damage in young rats
2003
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer
2004 Standout
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
1989
Dexrazoxane
1998
INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER
1999
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Cisplatin resistance in human cancers
1991
Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice
2002 StandoutNobel
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
2018 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24
1997
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
1993 Standout
Nasopharyngeal carcinoma
2019 Standout
Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer
1998 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Treatment of head and neck cancer: the role of chemotherapy
1996
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer
2003 Standout
A quantitative histometric murine in vivo model of radiation-induced oral mucositis
1998
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
2004 Standout
Status of hyperthermia in the treatment of advanced liver cancer
2001
Magnetically mediated hyperthermia: current status and future directions
2002
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
Chemotherapy in locally advanced head and neck cancer: a critical reappraisal
1995
Antitumor activity of cis‐diamminedichloroplatinum (II) depends on its time × concentration product against human gastric cancer cell lines in vitro
1995
Evaluation of ferromagnetic materials for low-frequency hysteresis heating of tumours
1992
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: Results from two randomized clinical trials
1993
Management of head and neck cancer
1994
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer
1990
Nasopharyngeal carcinoma
2015 Standout
Gefitinib — a novel targeted approach to treating cancer
2004
The pathobiology of mucositis
2004 Standout
Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)
2001
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
2004
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Adjuvant chemotherapy in head and neck cancer
1990
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
1990
Head and Neck Cancer
1993 Standout
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
2004
End points for new agents in induction chemotherapy for locally advanced head and neck cancers
2002
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck
2004
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer.
1991
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer
2003
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity
1998
Cardiac safety of liposomal anthracyclines
2004
Carcinoma of the tonsillar fossa: A nonrandomized comparison of irradiation alone or combined with surgery: Long‐term results
1991
A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results
1997
Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model
2001
Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials.
1996
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Plasmonic Nanobubbles Enhance Efficacy and Selectivity of Chemotherapy Against Drug‐Resistant Cancer Cells
2012
Continuous Infusion High-Dose Leucovorin with 5-Fluorouracil and Cisplatin for Untreated Stage IV Carcinoma of the Head and Neck
1990
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma
2002
Head and Neck Cancer
2001 Standout
A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck
1994
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Phase II Trial of Intratumoral Administration of ONYX-015, a Replication-Selective Adenovirus, in Patients With Refractory Head and Neck Cancer
2001
Paradigm Shift in the Treatment of Head and Neck Cancer: The Role of Neoadjuvant Chemotherapy
2005
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
High-dose rapid schedule chemotherapy for disseminated neuroblastoma
1992
Radiotherapy with Concomitant Chemotherapy for Head and Neck Cancer
1991
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Role of Taxoids in Head and Neck Cancer
2000
An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
2002 Standout
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Randomized Trials of Induction Chemotherapy: A Critical Review
1991
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Adjuvant chemotherapy in head and neck cancer
1992
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck
1997
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.
1987
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Structural Investigations into the Stereochemistry and Activity of a Phenylalanine-2,3-aminomutase from Taxus chinensis
2014 StandoutNobel
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
1991
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
2014
Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates
1991
THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
1997
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Adjuvant Chemotherapy in Head and Neck Cancer.
1992
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer
1991 Standout
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
2003
Targeted therapy for non-small cell lung cancer: current standards and the promise of the future.
2015
Works of J. Clark being referenced
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results.
1997
Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies
1988
Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines
1997
Docetaxel: an active drug for squamous cell carcinoma of the head and neck.
1996
Prevention and management of oral mucositis induced by antineoplastic therapy.
1991
Phase I study of gefitinib plus celecoxib in patients with metastatic and/or locally recurrent squamous cell carcinoma of the head and neck (SCCHN)
2004
T-Cell Subsets and Natural Killer Cell Function With Squamous Cell Carcinoma of the Head and Neck
1987
Phase I study of continuous-infusion cisplatin.
1986
Pathogenesis and prevention of doxorubicin cardiomyopathy.
1997
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck.
1987
Clinical Activity of Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Ros1 Gene Rearrangement
2012